GUGGENHEIM CAPITAL LLC - WUXI PHARMATECH CAYMAN INC ownership

WUXI PHARMATECH CAYMAN INC's ticker is WX and the CUSIP is 929352102. A total of 164 filers reported holding WUXI PHARMATECH CAYMAN INC in Q4 2013. The put-call ratio across all filers is 0.55 and the average weighting 0.6%.

Quarter-by-quarter ownership
GUGGENHEIM CAPITAL LLC ownership history of WUXI PHARMATECH CAYMAN INC
ValueSharesWeighting
Q3 2015$609,000
+15.3%
14,096
+12.9%
0.00%
+100.0%
Q2 2015$528,000
+0.6%
12,485
-7.7%
0.00%0.0%
Q1 2015$525,000
+10.8%
13,532
-4.0%
0.00%0.0%
Q4 2014$474,000
-25.9%
14,091
-22.9%
0.00%
-50.0%
Q3 2014$640,000
-0.8%
18,272
-6.8%
0.00%0.0%
Q2 2014$645,000
-19.8%
19,610
-10.0%
0.00%0.0%
Q1 2014$804,000
-10.3%
21,800
-6.6%
0.00%
-33.3%
Q4 2013$896,000
-73.3%
23,328
-80.9%
0.00%
-75.0%
Q3 2013$3,352,000
+24.5%
122,372
-4.6%
0.01%
+9.1%
Q2 2013$2,693,000128,2420.01%
Other shareholders
WUXI PHARMATECH CAYMAN INC shareholders Q4 2013
NameSharesValueWeighting ↓
Coupland Cardiff Asset Management LLP 1,055,000$40,491,00027.81%
DELTA PARTNERS LP 309,732$11,888,00013.39%
Black Creek Investment Management Inc. 2,457,034$94,301,00011.10%
Consonance Capital Management LP 1,252,314$48,064,0007.88%
Sloane Robinson LLP 247,700$9,507,0005.56%
GRATRY & Co LLC 205,800$7,899,0002.59%
Grandeur Peak Global Advisors, LLC 230,385$8,842,0002.36%
Mirae Asset Global Investments Co., Ltd. 1,130,882$43,403,0001.82%
Integre Asset Management, LLC 200,173$7,683,0001.74%
ROSENBLUM SILVERMAN SUTTON S F INC /CA 90,560$3,476,0001.64%
View complete list of WUXI PHARMATECH CAYMAN INC shareholders